AP1826A - A controlled release pharmaceutical composition and a process for preparing the same - Google Patents
A controlled release pharmaceutical composition and a process for preparing the sameInfo
- Publication number
- AP1826A AP1826A AP2006003597A AP2006003597A AP1826A AP 1826 A AP1826 A AP 1826A AP 2006003597 A AP2006003597 A AP 2006003597A AP 2006003597 A AP2006003597 A AP 2006003597A AP 1826 A AP1826 A AP 1826A
- Authority
- AP
- ARIPO
- Prior art keywords
- preparing
- same
- pharmaceutical composition
- controlled release
- release pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN417MU2003 | 2003-10-01 | ||
PCT/IN2004/000306 WO2005048978A2 (en) | 2003-10-01 | 2004-09-29 | A controlled release pharmaceutical composition and a process for preparing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2006003597A0 AP2006003597A0 (en) | 2006-04-30 |
AP1826A true AP1826A (en) | 2008-02-08 |
Family
ID=34611194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2006003597A AP1826A (en) | 2003-10-01 | 2004-09-29 | A controlled release pharmaceutical composition and a process for preparing the same |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070231385A1 (xx) |
EP (1) | EP1673072B1 (xx) |
CN (1) | CN1863512A (xx) |
AP (1) | AP1826A (xx) |
AT (1) | ATE358470T1 (xx) |
BR (1) | BRPI0415322A (xx) |
DE (1) | DE602004005734T2 (xx) |
EA (1) | EA008944B1 (xx) |
ES (1) | ES2286716T3 (xx) |
MX (1) | MXPA06003479A (xx) |
UA (1) | UA82564C2 (xx) |
WO (1) | WO2005048978A2 (xx) |
ZA (1) | ZA200603421B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
PL2155169T3 (pl) | 2007-06-08 | 2016-09-30 | Formulacja newirapiny o przedłużonym uwalnianiu | |
EP2923582B1 (en) * | 2009-07-14 | 2018-03-21 | Hill's Pet Nutrition, Inc. | Pet food compositions including sustained-release lipoic acid |
CN102247332B (zh) * | 2011-01-27 | 2015-03-25 | 济南久创化学有限责任公司 | 一种拉米夫定片及其制备方法 |
CN102225069B (zh) * | 2011-04-29 | 2013-05-08 | 陶珍珠 | 一种耐药性显著降低的药物组合物及其制备方法和其应用 |
AU2012264475A1 (en) * | 2011-05-30 | 2013-10-31 | Cipla Limited | Pharmaceutical antiretroviral composition |
WO2013111147A1 (en) * | 2011-12-19 | 2013-08-01 | Hetero Research Foundation | Extended release compositions of nevirapine |
CN107334743B (zh) * | 2016-07-15 | 2020-04-21 | 安徽贝克生物制药有限公司 | 一种齐多夫定、拉米夫定、奈韦拉平复方片及其制备方法 |
CN114392239B (zh) * | 2022-01-10 | 2023-06-27 | 安徽贝克生物制药有限公司 | 一种拉米夫定、齐多夫定和依非韦伦的复方片及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000018383A2 (en) * | 1998-09-28 | 2000-04-06 | Glaxo Group Limited | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester |
US6177435B1 (en) * | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE556141A (xx) * | 1956-03-27 | |||
GB8707421D0 (en) * | 1987-03-27 | 1987-04-29 | Wellcome Found | Pharmaceutical formulations |
IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
US6113920A (en) * | 1996-10-31 | 2000-09-05 | Glaxo Wellcome Inc. | Pharmaceutical compositions |
ZA200110500B (en) * | 2001-05-11 | 2002-04-03 | Cipla Medpro Pty Ltd | Pharmaceutical composition. |
-
2004
- 2004-09-29 AT AT04817650T patent/ATE358470T1/de not_active IP Right Cessation
- 2004-09-29 AP AP2006003597A patent/AP1826A/xx active
- 2004-09-29 EP EP04817650A patent/EP1673072B1/en active Active
- 2004-09-29 UA UAA200604821A patent/UA82564C2/uk unknown
- 2004-09-29 MX MXPA06003479A patent/MXPA06003479A/es active IP Right Grant
- 2004-09-29 US US10/574,320 patent/US20070231385A1/en not_active Abandoned
- 2004-09-29 BR BRPI0415322-7A patent/BRPI0415322A/pt not_active IP Right Cessation
- 2004-09-29 EA EA200600679A patent/EA008944B1/ru not_active IP Right Cessation
- 2004-09-29 CN CNA2004800288530A patent/CN1863512A/zh active Pending
- 2004-09-29 WO PCT/IN2004/000306 patent/WO2005048978A2/en active IP Right Grant
- 2004-09-29 ES ES04817650T patent/ES2286716T3/es active Active
- 2004-09-29 DE DE602004005734T patent/DE602004005734T2/de active Active
-
2006
- 2006-04-28 ZA ZA200603421A patent/ZA200603421B/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6177435B1 (en) * | 1992-05-13 | 2001-01-23 | Glaxo Wellcome Inc. | Therapeutic combinations |
WO2000018383A2 (en) * | 1998-09-28 | 2000-04-06 | Glaxo Group Limited | Antiviral combinations comprising (s)-2- ethyl-7- fluoro-3- oxo-3,4- dihydro-2h- quinoxaline-1- carboxylic acid isopropyl ester |
Also Published As
Publication number | Publication date |
---|---|
ATE358470T1 (de) | 2007-04-15 |
CN1863512A (zh) | 2006-11-15 |
UA82564C2 (uk) | 2008-04-25 |
EP1673072A2 (en) | 2006-06-28 |
US20070231385A1 (en) | 2007-10-04 |
EP1673072B1 (en) | 2007-04-04 |
WO2005048978A3 (en) | 2006-02-23 |
ZA200603421B (en) | 2007-09-26 |
WO2005048978A2 (en) | 2005-06-02 |
BRPI0415322A (pt) | 2006-12-05 |
ES2286716T3 (es) | 2007-12-01 |
DE602004005734T2 (de) | 2007-12-27 |
MXPA06003479A (es) | 2006-06-08 |
EA008944B1 (ru) | 2007-10-26 |
DE602004005734D1 (de) | 2007-05-16 |
AP2006003597A0 (en) | 2006-04-30 |
EA200600679A1 (ru) | 2006-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1523994A4 (en) | MEDICINAL REGULATED RELEASE COMPOSITION AND METHOD OF PREPARING THE SAME | |
IL165511A0 (en) | A process for preparing sulfoxide compounds compounds prepared thereby and pharmaceutical compositions containing the same | |
TWI347201B (en) | Pharmaceutical products,uses thereof and methods for preparing the same | |
TWI347202B (en) | Controlled release preparation | |
EP1187602A4 (en) | SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME | |
ZA200608117B (en) | Tetrahydroquinoline derivatives and a process for preparing the same | |
IL165977A (en) | Substituted pyrimidinylaminobenzamides , process for the preparation thereof and pharmaceutical compositions comprising the same | |
HK1167332A1 (en) | Pharmaceutical composition, use thereof and method for making the same | |
EP1706412A4 (en) | Novel pyridine derivatives, process for their preparation and pharmaceutical composition containing them | |
HK1118484A1 (en) | Medicament sustained-release particles and method for preparing the same | |
TWI370145B (en) | Water-soluble polyhydroxyaminoether and process for preparing the same | |
EP1731139A4 (en) | PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR | |
LT1729739T (lt) | Kietos farmacinės kompozicijos gamybos būdas | |
EP1370135A4 (en) | MEDIUM WITH PROTRACTIVE ACTIVE INGREDIENT AND METHOD FOR THE PRODUCTION THEREOF | |
GB2426704B (en) | Herbal oro-dental care composition and process for preparing the same | |
EP1834624A4 (en) | MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
PL394600A1 (pl) | Związek winyloazacykloalkanowy, sposób jego wytwarzania i jego zastosowanie oraz kompozycja farmaceutyczna | |
PL373328A1 (en) | Sustained release pharmaceutical prepartations and methods for producing the same | |
IL150910A0 (en) | Agrochemical composition containing phosphite and process for the preparation thereof | |
HK1102395A1 (en) | Indene derivatives and process for the preparation thereof | |
IL175408A0 (en) | A soil-fumigant-containing material and a process for the preparation thereof | |
EP1537083A4 (en) | S - (-) - AMLODIPINNICOTINATE AND METHOD FOR THE PRODUCTION THEREOF | |
AP1826A (en) | A controlled release pharmaceutical composition and a process for preparing the same | |
EP1756036A4 (en) | INDENED DERIVATIVES AND PROCESS FOR THEIR PREPARATION | |
HK1100946A1 (en) | 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF |